Journal of Medicinal Chemistry p. 7355 - 7366 (2014)
Update date:2022-08-04
Topics:
Lu, Yan
Chen, Jianjun
Wang, Jin
Li, Chien-Ming
Ahn, Sunjoo
Barrett, Christina M.
Dalton, James T.
Li, Wei
Miller, Duane D.
To block the metabolically labile sites of novel tubulin inhibitors targeting the colchicine binding site based on SMART, ABI, and PAT templates, we have designed, synthesized, and biologically tested three focused sets of new derivatives with modifications at the carbonyl linker, the para-position in the C ring of SMART template, and modification of A ring of the PAT template. Structure-activity relationships of these compounds led to the identification of new benzimidazole and imidazo[4,5-c]pyridine-fused ring templates, represented by compounds 4 and 7, respectively, which showed enhanced antitumor activity and substantially improved the metabolic stability in liver microsomes compared to SMART. MOM group replaced TMP C ring and generated a potent analogue 15, which showed comparable potency to the parent SMART compound. Further modification of PAT template yielded another potent analogue 33 with 5-indolyl substituent at A ring.
View MoreShanghai better-in Medical Technology Co.,LTD.
Contact:+86-21-38921049
Address:Lane 720 zhangjianggaoke cailun road, Pudong, Shanghai, room 513
website:http://www.afinechem.com
Contact:+86-571-85134551
Address:No. 206 Zhen Hua Road, Hangzhou 310030, Zhejiang, China
Nanjing Chemzam Pharmtech Co., Ltd.
Contact:+86-25-86462165,+86-13915979898
Address:C5-1,6 Maiyue Road,Maigaoqiao,Nanjing,Jiangsu,China
Contact:.+86-579-85566777
Address:12222222222dsadsdsdeeeee
Chengdu Chengnuo New-Tech Co., Ltd
Contact:0086-028-85749078
Address:4 Jiuyang road,Jiulong industrial port,Chengdu, China
Doi:10.1016/j.jfluchem.2011.05.005
(2011)Doi:10.1021/jm200629m
(2011)Doi:10.1016/0022-328X(91)86256-P
(1991)Doi:10.1002/cssc.201100106
(2011)Doi:10.1039/c8md00399h
(2018)Doi:10.1002/asia.201100836
(2012)